Quantitative Adenovirus Assay Better Informs Post-Transplant Care: Joseph Yao, M.D.
Failed to add items
Add to basket failed.
Add to Wish List failed.
Remove from Wish List failed.
Follow podcast failed
Unfollow podcast failed
Quantitative Adenovirus Assay Better Informs Post-Transplant Care: Joseph Yao, M.D.
-
Narrated by:
-
By:
About this listen
Joseph Yao, M.D., explains how Mayo Clinic Laboratories' new quantitative assay (Mayo ID: ADVQU) goes beyond qualitative testing to evaluate transplant patients for adenovirus infection. Adenovirus can cause life-threatening disease in immunocompromised transplant patients, especially children.
(01:14)
Could you give us a brief overview of this assay?
(02:06)
Can you explain the differences of the qualitative and quantitative methods and why we made the change to a quantitative adenovirus method?
(04:00)
When is this test typically ordered for transplant patients? Is it used throughout their treatment?
(06:56)
Could an immunocompromised person be unknowingly infected?
(07:31)
Is our quantitative method approved for pediatric patients?
(08:00)
How are the test results used to treat patients?
(10:36)
What other infections might providers consider alongside adeovirus?